Translating RNA
Language Into Medicines.

Therna Biosciences

Therna is pioneering programmable RNA medicines with the first AI RNA Biologist, RNA-Logix™, built on proprietary data the Company generates itself. Our biologists and AI researchers work side by side to discover biology others have not characterized, then design the medicines that act on it. Our integrated approach delivers the biology and a lab-validated candidate together, shortening the time from idea to potential new medicine.

From Model to Molecule

RNA-Logix™ is an AI RNA Biologist that unlocks new biology and designs novel medicines, trained on the largest proprietary RNA data set in the field.

Explore Our Approach

Advancing RNA Medicines

Translating programmable RNA design into medicines for cardiovascular, metabolic, and immunological diseases – including single-patient programs for ultra-rare conditions.

Discover Our Pipeline

Experienced Team at the Intersection of RNA Biology and AI

Therna’s team combines decades of experience in RNA biology, artificial intelligence, and drug development to guide intelligent design from model to molecule and into medicines for patients.

Meet Our Team

Meaningful Work at the Frontier of RNA Medicine

Join our team of scientists and AI researchers working across RNA biology, AI, and experimental execution to discover future medicines for patients.

Join Our Team
Therna Biosciences Showcases RNA-Logix™, Its AI RNA Biologist Platform for Biological Discovery and Genomic Medicine Design
Read Article ▸
Therna Biosciences Advances Corporate and Scientific Objectives with a New Chief Operating Officer, Two AI Advisors, and NIH Challenge Win
Read Article ▸
Therna Biosciences Releases Chronos, the Data Engine Behind its AI RNA Biologist
Read Article ▸